ATRenew Sees Q4 Sales $1.160B-$1.175B vs $1.040B Est

Benzinga · 2d ago
ATRenew (NYSE:RERE) sees Q4 sales of $1.160 billion-$1.175 billion vs $1.040 billion analyst estimate.